Godlike Productions - Discussion Forum
Users Online Now: 1,940 (Who's On?)Visitors Today: 985,166
Pageviews Today: 1,760,092Threads Today: 753Posts Today: 13,425
07:57 PM


Back to Forum
Back to Forum
Back to Thread
Back to Thread
REPLY TO THREAD
Subject A TOBACCO Giant Joins Forces With The Military Industrial Complex - DARPA - To Create EBOLA VACCINE From TOBACCO.
User Name
 
 
Font color:  Font:








In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
Original Message [link to newsdaily.com]

The tobacco leaf is being used to fight ebola. However, at this time tobacco leaves are hard to produce on a large scale.

The two doctors, Kent Brantly and Nancy Writebol, who had gotten ebola in Liberia, are improving from taking the vaccine from the tobacco leaf.

The West African outbreak is the largest in history. It has killed 887 of the more than 1,600 infected.

Proteins called monoclonal antibodies bind to and inactivate ebola.

The tobacco plant produced monoclonals have been dubbed "plantibodies."

There is a use for every type of plant God has given us.
It is up to us to find it.

It is rather strange that the Military Industrial Complex has gotten together with Phillips Morris to work on the ebola vaccine.

This had to be in the works for awhile...right in time for this outbreak.

FROM LINK:


In 2007, Kentucky Bioprocessing entered into an agreement with Mapp Biopharmaceutical and the Biodesign Institute of Arizona State University to refine the tobacco-plant approach. The approach attracted funding support from the Pentagon’s Defense Advanced Research Projects Agency (DARPA).

For all the hope, however, the plant technique has delivered few commercial products. In 2012 the FDA okayed a drug for the rare genetic disorder Gaucher disease from Israel’s Protalix BioTherapeutics and Pfizer. Called Elelyso, it is made in carrot cells, and is the only such drug to reach the market.

Other companies have fallen far short, though it is not clear if the technique was to blame. Calgary-based SemBioSys Genetics Inc, which used safflowers to produce an experimental diabetes drug, folded in 2012 before it finished clinical trials.

Even Kentucky Bioprocessing, which at one point was developing monoclonal antibodies against HIV (the virus that causes AIDS), C. difficile bacterial infection, and the human papillomavirus, has dropped the last two projects, Howard said.

Last year Mitsubishi Tanabe Pharma Corp acquired a majority share of Quebec City-based Medicago, which is developing influenza and other vaccines using the tobacco-plant technology. The other 40 percent is owned by tobacco giant Philip Morris International.
Pictures (click to insert)
5ahidingiamwithranttomatowtf
bsflagIdol1hfbumpyodayeahsure
banana2burnitafros226rockonredface
pigchefabductwhateverpeacecool2tounge
 | Next Page >>





GLP